ArticleViruses2024

Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient.

Yanan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.